Meta Platforms upgraded, Okta downgraded: Wall Street's top analyst calls

• Arete upgraded Meta Platforms (META) to Buy from Neutral with a terms people of $735, up from $614. The steadfast cites Meta's "flexible" outgo base, subscription growth, and interior AI advancement for the upgrade.

• Wedbush upgraded TripAdvisor (TRIP) to Outperform from Neutral with a terms people of $19, up from $12, pursuing a transportation successful expert coverage. TripAdvisor has "underappreciated catalysts," including its governance translation that eliminated controlled-company status, activistic engagement by Starboard Value, a strategical reappraisal process for TheFork, and an "emerging AI narrative" fixed its "large and valuable" question dataset and precocious signed concern deals with OpenAI, the steadfast tells investors successful a probe note.

• Wedbush upgraded Abivax (ABVX) to Neutral from Underperform with a terms people of $90, down from $110. The steadfast notes the institution reported placebo-adjusted attraction objective remission rates of 40% supra its benchmark expectations of 20%-30%, but disclosed malignancies astatine the higher dose of 50 mg QD, which increases hazard for an eventual achromatic container warning, and anterior to approval, an FDA AdComm.

• Susquehanna upgraded Knight-Swift (KNX) to Positive from Neutral with a terms people of $90, up from $72. The steadfast cites the company's increasing publication from little than truckload and its "higher-quality" net premix for the upgrade.

• Raymond James upgraded Atlas Energy (AESI) to Outperform from Market Perform with a $25 terms target. The company's Q1 results brought clarity astir its "materially increased" distributed powerfulness maturation plans, the steadfast tells investors successful a probe note.

Top 5 Downgrades:

• Mizuho downgraded Okta (OKTA) to Neutral from Outperform with a terms people of $125, up from $110. Mizuho believes the institution is good positioned to capitalize connected agentic AI, but says the timing and magnitude "remain large question marks astatine this aboriginal stage."

• Goldman Sachs downgraded Intuit (INTU) to Sell from Neutral with a terms people of $276, down from $519. The steadfast believes statement estimates numbers are apt excessively precocious for the adjacent 3 years, and that Intuit whitethorn person to revise its semipermanent maturation targets lower.

• Piper Sandler treble downgraded Fulcrum Therapeutics (FULC) to Underweight from Overweight with a terms people of $3, down from $23. The institution is discontinuing the improvement of pociredir for the attraction of sickle compartment illness aft the FDA highlighted concerns regarding the imaginable secondary hematologic malignancies, the steadfast tells investors successful a probe note. Leerink, Stifel, Truist and H.C. Wainwright besides downgraded the banal but to Neutral-equivalent ratings.

• UBS downgraded Sherwin-Williams (SHW) to Neutral from Buy with a terms people of $330, down from $385. The company's net are highly leveraged to a U.S. lodging recovery, and the "unsupportive lodging marketplace pushes that timeline further out," the steadfast tells investors successful a probe note.

• JPMorgan downgraded SQM (SQM) to Neutral from Overweight with a terms people of $100, up from $94. The steadfast sees constricted upside to lithium prices from the existent spot levels.